|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00822003 |
|
Date of registration:
|
13/01/2009 |
|
Primary sponsor: |
|
|
Public title:
|
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
No |
|
Scientific title:
|
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile Following an Oral Glucose Tolerance Test in Healthy Male Subjects |
|
Date of first enrolment:
|
February 2008 |
|
Target sample size:
|
16 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00822003 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Christoph Beglinger, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Clinical Research Center, University Hospital Basel |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- healthy male subjects
- no gastrointestinal or endocrine disorder
Exclusion Criteria:
- females
- alcohol or drug abuse
- active virus hepatitis
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Glucose Homeostasis
|
|
Intervention(s)
|
|
Drug: Oral GLP-1
|
|
Drug: Placebo
|
|
Secondary Outcome(s)
|
|
Glucagon secretion GH release adverse events
[Time Frame: Yes]
|
|
Secondary ID(s)
|
|
EKBB 127/07, Amendment 1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|